ArthroCare has experienced a year-on-year increase in its revenues during the first quarter of 2010.
Figures from the firm’s latest financial report reveal that total first quarter revenues rose from $78.8 million (52.4 million pounds) to $90.6 million between 2009 and 2010, driven by increased sales.
The surgical product specialist’s central sports medicine and ear, nose and throat units were central to this growth, with sales in these sectors having increased across all territories.
In addition, the firm also highlighted its success in reducing its administrative expenses in the last quarter, thanks to cost-effectiveness initiatives in its sales and marketing activities.
ArthroCare added that it “continues to focus on working capital efficiency, process improvements and cash conversion”.
Last month, the company reported on new trial data for its Plasma Disc Decompression range published in the Journal of Neurosurgery: Spine, which demonstrated the devices’ effectiveness in treating pain among back injury patients.
Source: Arthrocare
published: May 14, 2010 in: Arthroscopy, Financial, Products